This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sales, K. J. Articles by Jabbour, H. N. Search for Related Content PubMed PubMed Citation Articles by Sales, K. J. Articles by Jabbour, H. N.

Expression, Localization, and Signaling of Prostaglandin F₂ Receptor in Human Endometrial Adenocarcinoma: Regulation of Proliferation by Activation of the Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling Pathways

Medical Research Council Human Reproductive Sciences Unit, Center for Reproductive Biology (K.J.S., R.A.A., H.N.J.), and Department of Pathology, University of Edinburgh Academic Center (A.R.W.W.), Edinburgh, United Kingdom EH16 4SB; and Fujisawa Institute of Neuroscience in Edinburgh, University of Edinburgh (S.A.M.), Edinburgh, United Kingdom EH8 9LE

Address all correspondence and requests for reprints to: Dr. Henry N. Jabbour, Medical Research Council Human Reproductive Sciences Unit, Center for Reproductive Biology, University of Edinburgh Academic Center, 49 Little France Crescent, Old Dalkeith Road, Edinburgh, United Kingdom EH16 4SB. E-mail: h.jabbour{at}hrsu.mrc.ac.uk.

Prostaglandin F₂(PGF₂) is a bioactive lipid biosynthesized by cyclooxygenase (COX) enzymes and mediates its biological activity via the heptahelical G_q-coupled PGF₂receptor (FP receptor). This study investigated the expression and molecular signaling of the FP receptor in human endometrial adenocarcinomas. Real-time RT-PCR and Western blot analysis confirmed FP receptor expression in endometrial adenocarcinoma of all grades and differentiation. The expression of FP receptor was up-regulated in all endometrial adenocarcinomas compared with normal endometrium. The site of FP receptor expression was localized by in situ hybridization and immunohistochemistry to the neoplastic epithelial cells in all adenocarcinomas. Treatment of endometrial adenocarcinoma explants with PGF₂ resulted in mobilization of inositol phosphate signaling, indicating functional FP receptor expression. We investigated whether PGF₂ could trans-activate the epidermal growth factor receptor (EGFR) and trigger the MAPK signaling pathway. Treatment of adenocarcinoma explants and endometrial adenocarcinoma cells (Ishikawa) with PGF₂-phosphorylated EGFR, triggered MAPK signaling and enhanced the proliferation of Ishikawa cells. Inactivation of phospholipase C, EGFR kinase, and MAPK kinase with specific inhibitors abolished PGF₂-induced trans-activation of EGFR, MAPK signaling, and Ishikawa cell proliferation. These data suggest that PGF₂-FP receptor promote endometrial tumorigenesis via a phospholipase C-mediated phosphorylation of the EGFR and MAPK signaling pathways.

Abbreviations: COX, Cyclooxygenase; d, deoxy; DMSO, dimethylsulfoxide; EGF, epidermal growth factor; EGFR, EGF receptor; FCS, fetal calf serum; FITC, fluorescein isothiocyanate; FP, GPCR for prostaglandin F₂; GPCR, G protein receptor; IP3, inositol trisphosphate; MEK, MAPK kinase; PGF₂, prostaglandin F₂; PLC, phospholipase C.

This article has been cited by other articles:

				K. Wanggren, A. Stavreus-Evers, C. Olsson, E. Andersson, and K. Gemzell-Danielsson Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens Hum. Reprod., October 1, 2008; 23(10): 2359 - 2368. [Abstract] [Full Text] [PDF]

				D. Hughes, T. Otani, P. Yang, R. A. Newman, R. K. Yantiss, N. K. Altorki, J. L. Port, M. Yan, S. D. Markowitz, M. Mazumdar, et al. NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non-Small Cell Lung Cancer Cancer Prevention Research, September 1, 2008; 1(4): 241 - 249. [Abstract] [Full Text] [PDF]

				J. Evans, R. D. Catalano, K. Morgan, H. O. D. Critchley, R. P. Millar, and H. N. Jabbour Prokineticin 1 Signaling and Gene Regulation in Early Human Pregnancy Endocrinology, June 1, 2008; 149(6): 2877 - 2887. [Abstract] [Full Text] [PDF]

				K. J. Sales, S. C. Boddy, A. R. W. Williams, R. A. Anderson, and H. N. Jabbour F-Prostanoid Receptor Regulation of Fibroblast Growth Factor 2 Signaling in Endometrial Adenocarcinoma Cells Endocrinology, August 1, 2007; 148(8): 3635 - 3644. [Abstract] [Full Text] [PDF]

				K. Wanggren, P.G. Lalitkumar, A. Stavreus-Evers, B. Stabi, and K. Gemzell-Danielsson Prostaglandin E2 and F2{alpha} receptors in the human Fallopian tube before and after mifepristone treatment Mol. Hum. Reprod., September 1, 2006; 12(9): 577 - 585. [Abstract] [Full Text] [PDF]

				M. Muller, K. J. Sales, A. A. Katz, and H. N. Jabbour Seminal Plasma Promotes the Expression of Tumorigenic and Angiogenic Genes in Cervical Adenocarcinoma Cells via the E-Series Prostanoid 4 Receptor Endocrinology, July 1, 2006; 147(7): 3356 - 3365. [Abstract] [Full Text] [PDF]

				O. P. Milling Smith, S. Battersby, K. J. Sales, H. O. D. Critchley, and H. N. Jabbour Prostacyclin Receptor Up-Regulates the Expression of Angiogenic Genes in Human Endometrium via Cross Talk with Epidermal Growth Factor Receptor and the Extracellular Signaling Receptor Kinase 1/2 Pathway Endocrinology, April 1, 2006; 147(4): 1697 - 1705. [Abstract] [Full Text] [PDF]

				H. N. Jabbour, K. J. Sales, S. C. Boddy, R. A. Anderson, and A. R. W. Williams A Positive Feedback Loop that Regulates Cyclooxygenase-2 Expression and Prostaglandin F2{alpha} Synthesis via the F-Series-Prostanoid Receptor and Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway Endocrinology, November 1, 2005; 146(11): 4657 - 4664. [Abstract] [Full Text] [PDF]

				K. J. Sales, T. List, S. C. Boddy, A. R.W. Williams, R. A. Anderson, Z. Naor, and H. N. Jabbour A Novel Angiogenic Role for Prostaglandin F2{alpha}-FP Receptor Interaction in Human Endometrial Adenocarcinomas Cancer Res., September 1, 2005; 65(17): 7707 - 7716. [Abstract] [Full Text] [PDF]

				E. G. A. Harks, P. H. J. Peters, J. L. J. van Dongen, E. J. J. van Zoelen, and A. P. R. Theuvenet Autocrine production of prostaglandin F2{alpha} enhances phenotypic transformation of normal rat kidney fibroblasts Am J Physiol Cell Physiol, July 1, 2005; 289(1): C130 - C137. [Abstract] [Full Text] [PDF]